BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 29059435)

  • 1. Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer.
    Stacpoole PW
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy.
    Anwar S; Shamsi A; Mohammad T; Islam A; Hassan MI
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188568. PubMed ID: 34023419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors.
    Zhang W; Hu X; Zhou W; Tam KY
    J Proteome Res; 2018 Sep; 17(9):3012-3021. PubMed ID: 30028142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Pyruvate Dehydrogenase Kinase as a Therapeutic Strategy against Cancer.
    Sradhanjali S; Reddy MM
    Curr Top Med Chem; 2018; 18(6):444-453. PubMed ID: 29788890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the pyruvate dehydrogenase complex/pyruvate dehydrogenase kinase (PDC/PDK) axis to discover potent PDK inhibitors through structure-based virtual screening and pharmacological evaluation.
    Gan L; Yang Y; Liang Z; Zhang M; He Y; Zhang SL
    Eur J Med Chem; 2024 Jan; 264():116008. PubMed ID: 38056298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibition of PDKs by phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by combination with dichloroacetate.
    Ferriero R; Iannuzzi C; Manco G; Brunetti-Pierri N
    J Inherit Metab Dis; 2015 Sep; 38(5):895-904. PubMed ID: 25601413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel inhibitor of pyruvate dehydrogenase kinase stimulates myocardial carbohydrate oxidation in diet-induced obesity.
    Wu CY; Satapati S; Gui W; Wynn RM; Sharma G; Lou M; Qi X; Burgess SC; Malloy C; Khemtong C; Sherry AD; Chuang DT; Merritt ME
    J Biol Chem; 2018 Jun; 293(25):9604-9613. PubMed ID: 29739849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nematode pyruvate dehydrogenase kinases: role of the C-terminus in binding to the dihydrolipoyl transacetylase core of the pyruvate dehydrogenase complex.
    Chen W; Komuniecki PR; Komuniecki R
    Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):103-9. PubMed ID: 10085233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia.
    Sugden MC; Holness MJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):151-65. PubMed ID: 12476789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pyruvate dehydrogenase complex in cancer: An old metabolic gatekeeper regulated by new pathways and pharmacological agents.
    Saunier E; Benelli C; Bortoli S
    Int J Cancer; 2016 Feb; 138(4):809-17. PubMed ID: 25868605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic mechanisms underlying X-linked Charcot-Marie-Tooth neuropathy (CMTX6) in patients with a pyruvate dehydrogenase kinase 3 mutation.
    Perez-Siles G; Ly C; Grant A; Drew AP; Yiu EM; Ryan MM; Chuang DT; Tso SC; Nicholson GA; Kennerson ML
    Neurobiol Dis; 2016 Oct; 94():237-44. PubMed ID: 27388934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Warburg Effect of Melatonin: A Proposed Mechanism to Explain its Inhibition of Multiple Diseases.
    Reiter RJ; Sharma R; Rosales-Corral S
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β1 is a regulator of the pyruvate dehydrogenase complex in fibroblasts.
    Smith ER; Hewitson TD
    Sci Rep; 2020 Oct; 10(1):17914. PubMed ID: 33087819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCKDK regulates the TCA cycle through PDC in the absence of PDK family during embryonic development.
    Heinemann-Yerushalmi L; Bentovim L; Felsenthal N; Vinestock RC; Michaeli N; Krief S; Silberman A; Cohen M; Ben-Dor S; Brenner O; Haffner-Krausz R; Itkin M; Malitsky S; Erez A; Zelzer E
    Dev Cell; 2021 Apr; 56(8):1182-1194.e6. PubMed ID: 33773101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of pyruvate dehydrogenase in the common killifish, Fundulus heteroclitus, during hypoxia exposure.
    Richards JG; Sardella BA; Schulte PM
    Am J Physiol Regul Integr Comp Physiol; 2008 Sep; 295(3):R979-90. PubMed ID: 18579651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyruvate dehydrogenase kinases (PDKs): an overview toward clinical applications.
    Wang X; Shen X; Yan Y; Li H
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33739396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Flexibility in Cancer: Targeting the Pyruvate Dehydrogenase Kinase:Pyruvate Dehydrogenase Axis.
    Woolbright BL; Rajendran G; Harris RA; Taylor JA
    Mol Cancer Ther; 2019 Oct; 18(10):1673-1681. PubMed ID: 31511353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pyruvate carboxylase-pyruvate dehydrogenase axis in islet pyruvate metabolism: Going round in circles?
    Sugden MC; Holness MJ
    Islets; 2011; 3(6):302-19. PubMed ID: 21934355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed evaluation of pyruvate dehydrogenase complex inhibition in simulated exercise conditions.
    Jelinek BA; Moxley MA
    Biophys J; 2021 Mar; 120(5):936-949. PubMed ID: 33515599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation.
    Holness MJ; Sugden MC
    Biochem Soc Trans; 2003 Dec; 31(Pt 6):1143-51. PubMed ID: 14641014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.